Duncan McKechnie sold $2.4M of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 25, disclosed Feb 26, 1 day later.

Value, as filed

$2.4M

4,910 sh across 2 lots

Executed

Feb 25

the trade date, as filed

Disclosed

Feb 26

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DM Duncan McKechnie EVP, Chief Commercial Officer profile →

Duncan McKechnie (EVP, Chief Commercial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $2.4M of VRTX (4,910 sh across 2 lots, as filed), executed Feb 25.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 90 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Duncan McKechnie in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $800K
1,541 sh × $519.00
Exec Jul 2
Filed Jul 7 · 4:08 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.3M
2,633 sh × $498.42
Exec Mar 11
Filed Mar 13 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.2M
2,437 sh × $475.30
Exec Mar 4
Filed Mar 6 · 5:30 PM ET